Skip to main content
Caplight Logo









NYB Group

NYB Group

Private
SingaporeEnterprise Softwarehttps://www.nyb.group/

Last Round

M&A

Oct 2, 2025

Total Funding Raised

$10M

Company Overview

NYB Group is an AI-native biotechnology company that leverages artificial intelligence and computational drug discovery to develop natural-product-derived therapeutics and nutraceuticals for oncology, metabolic health, and chronic diseases.

Sector

Enterprise Software

Verticals

Compliance & Risk

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

business consultingfinancial advisorymanagement consultingcorporate managementmarket entry servicesMENA business consultingstrategic planningoperational efficiencystrategy firmdrug discoveryAI biotechAI drug discoverygraph deep learningin silico discoverynutraceutical development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NYB Group Comparables

Compare NYB Group with similar companies based on industry and business-model similarity.

NYB Group comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Numerion Labs
32%

NYB Group Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AOct 2, 2025
AcceleratorSep 1, 2024

NYB Group Investors

Notable investors and investment history

NYB Group investors
InvestorRounds
Mercatus CapitalSeed
Tribe AcceleratorAccelerator
The Ignition AI AcceleratorAccelerator

NYB Group Filings

Explore SEC and related filing metadata, where available.

NYB Group filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NYB Group's valuation, stock price, and market status.

Is NYB Group a public or private company?

NYB Group is a private company.

What is the current stock price of NYB Group?

NYB Group is a private company with no public stock price. Caplight tracks NYB Group's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is NYB Group worth (valuation)?

Valuation information for NYB Group is not publicly available.

Can I buy NYB Group stock?

NYB Group shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NYB Group's last funding round?

NYB Group's most recent funding round was M&A on October 2, 2025.

Who are the main investors in NYB Group?

Key investors in NYB Group include Mercatus Capital, Tribe Accelerator, The Ignition AI Accelerator.

Will NYB Group IPO soon?

No public IPO plans have been announced for NYB Group.

How can I track NYB Group secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NYB Group's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSingapore
Year Founded2021
Last FundingOct 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?